Characterisation of carried and invasive Neisseria meningitidis isolates in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation

Chen, M.; Rodrigues, C. M. C.; Harrison, O. B.; Zhang, C.; Tan, T.; Chen, J.; Zhang, X.; Maiden, M. C. J.

doi:10.1101/284133

Home/Archive/bioRxiv

bioRxiv · 10.1101/284133

Characterisation of carried and invasive Neisseria meningitidis isolates in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation

Chen, M.·Rodrigues, C. M. C.·Harrison, O. B.·Zhang, C.·Tan, T.·Chen, J.·Zhang, X.·Maiden, M. C. J.

View original source ↗Export metadata ↓

Abstract

BackgroundSerogroup B invasive meningococcal disease (IMD) is increasing in China, little is known however, about these meningococci. This study characterises a collection of isolates associated with IMD and carriage in Shanghai and assesses current vaccine strategies.\n\nMethodsIMD epidemiological data in Shanghai from 1950-2016 were obtained from the National Notifiable Diseases Registry System, with 460 isolates collected for analysis including, 169 from IMD and 291 from carriage. Serogroup B meningococcal (MenB) vaccine coverage was evaluated using Bexsero(R) Antigen Sequence Type (BAST).\n\nResultsSeven IMD epidemic periods have been observed in Shanghai since 1950, with incidence peaking from February to April. Analyses were divided according to the period of meningococcal polysaccharide vaccine (MPV) introduction: (i) pre-MPV-A, 1965-1980; (ii) post-MPV-A, 1981-2008; and (iii) post-MPV-A+C, 2009-2016. IMD incidence decreased from 55.4/100,000 to 0.71 then to 0.02, and corresponded with shifts from serogroup A ST-5 complex (MenA:cc5) to MenC:cc4821 then MenB:cc4821. MenB IMD became predominant (63.2%) in the post-MPV-A+C period, of which 50% were caused by cc4821, with the highest incidence in infants (0.45/100,000) and a case-fatality rate of 9.5%. IMD was positively correlated with carriage rates. Data indicate that fewer than 25% of MenB isolates in the post-MPV-A+C period may be covered by the vaccines Bexsero(R), Trumenba(R), or a PorA-based vaccine, NonaMen.\n\nConclusionsA unique IMD epidemiology is found in China, changing periodically from hyperepidemic to low-level endemic disease. MenB IMD now dominates in Shanghai, with isolates harbouring diverse antigenic variants potentially beyond coverage with licenced OMV- and protein-based MenB vaccines.\n\nSummaryMeningococcal disease in Shanghai, China is described and current vaccine approaches evaluated. Since 1950, MenA:cc5 shifted to MenC:cc4821 then MenB:cc4821, with MenB dominating since 2009. Distinct antigens potentially beyond coverage with licensed OMV- and protein-based MenB vaccines were found.

Source connections

Published article ↗

Explore related subjects

epidemiology Preprint

Keep this discovery

BibTeX RIS

Chen, M., Rodrigues, C. M. C., Harrison, O. B., Zhang, C., Tan, T., Chen, J., Zhang, X., Maiden, M. C. J.. 2018-03-20. Characterisation of carried and invasive Neisseria meningitidis isolates in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation. https://doi.org/10.1101/284133

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2018

Translating surveillance data into incidence estimates

Monitoring a population for a disease requires the hosts to be sampled and tested for the pathogen. This results in sampling series from which to estimate the disease incidence, i.e. the proportion of hosts infected. Existing estimation methods assume that disease incidence is not changing between monitoring rounds, resulting in underestimation of the disease incidence. In this paper we develop an incidence estimation model accounting for epidemic growth with monitoring rounds sampling varying incidence. We also show how to accommodate the asymptomatic period characteristic to most diseases. For practical use, we produce an approximation of the model, which is subsequently shown accurate for relevant epidemic and sampling parameters. Both the approximation and the full model are applied to stochastic spatial simulations of epidemics. The results prove their consistency for a very wide range of situations.

epidemiology↗

bioRxiv2018

The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results

Primary Ciliary Dyskinesia (PCD) is a rare hereditary, multi-organ disease caused by defects in ciliary structure and function. It results in a wide range of clinical manifestations, most commonly in the upper and lower airways. Central data collection in national and international registries is essential to studying the epidemiology of rare diseases and filling in gaps in knowledge of diseases such as PCD. For this reason, the Swiss Primary Ciliary Dyskinesia Registry (CH-PCD) was founded in 2013 as a collaborative project between epidemiologists and adult and paediatric pulmonologists.\n\nThe registry records patients of any age, suffering from PCD, who are treated and resident in Switzerland. It collects information from patients identified through physicians, diagnostic facilities, and patient organisations. The registry dataset contains data on diagnostic evaluations, lung function, microbiology and imaging, symptoms, treatments, and hospitalizations.\n\nBy May 2018, CH-PCD has contacted 566 physicians of different specialties and identified 134 patients with PCD. At present this number represents an overall 1 in 63,000 prevalence of people diagnosed with PCD in Switzerland. Prevalence differs by age and region; it is highest in children and adults younger than 30 years, and in Espace Mittelland. The median age of patients in the registry is 25 years (range 5-73), and 49 patients have a definite PCD diagnosis based on recent international guidelines. Data from CH-PCD are contributed to international collaborative studies and the registry facilitates patient identification for nested studies.\n\nCH-PCD has proven to be a valuable research tool that already has highlighted weaknesses in PCD clinical practice in Switzerland. Development of centralised diagnostic and management centres and adherence to international guidelines are needed to improve diagnosis and management--particularly for adult PCD patients.

epidemiology↗

bioRxiv2018

Perfect Counterfactuals for Epidemic Simulations

Simulation studies are often used to predict the expected impact of control measures in infectious disease outbreaks. Typically, two independent sets of simulations are conducted, one with the intervetnion, and one without, and epidemic sizes (or some related metric) are compared to estimate the effect of the intervention. Since it is possible that controlled epidemics are larger than uncontrolled ones if there is substantial stochastic variation between epidemics, uncertainty intervals from this approach can include a negative effect even for an effective intervention. To more precisely estimate the number of cases an intervention will prevent within a single epidemic, here we develop a single world approach to matching simulations of controlled epidemics to their exact uncontrolled counterfac-tual. Our method borrows concepts from percolation approaches prune out possible epidemic histories and create potential epidemic graph that can be realized to create perfectly matched controlled and uncontrolled epidemics. We present an implementation of this method for a common class of compartmental models, and its application in a simple SIR model. Results illustrate how, at the cost of some computation time, this method substantially narrows confidence intervals and avoids non-sensical inferences.

epidemiology↗